The Life Sciences Virtual Investor Forum, scheduled for March 11 and 12, 2026, offers a significant opportunity for public companies across therapeutic and healthcare markets to engage directly with a global audience of investors. This virtual event, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, allows presenting companies to deliver live executive presentations followed by real-time question-and-answer sessions. Investors can further request one-on-one meetings with management teams through the platform, creating multiple touchpoints for meaningful dialogue.
B2i Digital, Inc. serves as the Official Marketing Partner for the event, supporting awareness through digital marketing, social media promotion, and broader investor outreach. The company's partnership with Virtual Investor Conferences helps extend visibility for participating organizations beyond the live sessions, with presentation replays available for on-demand viewing. This extended engagement window allows companies to reach investors who may not be able to attend the live presentations, maximizing the forum's impact.
The presenting company roster includes organizations across diverse therapeutic areas and markets. On March 11, presentations will feature SeaStar Medical Holding Corporation, Nasus Pharma Ltd., Tonix Pharmaceuticals Holding Corp., and Jupiter Neurosciences, Inc. The March 12 schedule includes Bora Pharmaceuticals, Prostatype Genomics AB, MetaVia Inc., Phio Pharmaceuticals Corp., Avicanna Inc., EMVision Medical Devices Ltd., Aethlon Medical, Dyadic International, Jaguar Health, Inc., Beyond Air, Inc., Cadrenal Therapeutics, Inc., and Amplia Therapeutics Ltd. Among these, Jupiter Neurosciences, Inc. and Phio Pharmaceuticals Corp. are designated as B2i Digital Featured Companies.
Virtual Investor Conferences, an OTC Markets Group Inc. property, regularly hosts companies listed on major exchanges including NYSE, Nasdaq, TSX, CSE, ASX, and OTC Markets. The platform's interactive format provides efficient access to a broad investor audience while offering investors direct access to executive management teams. For comprehensive profiles of participating companies and registration details, investors can visit the Virtual Investor Conferences registration page.
The forum's importance lies in its ability to bridge the gap between life sciences companies seeking investment and investors looking for opportunities in the healthcare sector. By facilitating direct communication between management teams and the investment community, the event supports capital formation for companies developing innovative therapies and medical technologies. This connection is particularly valuable in the life sciences sector, where research and development timelines are lengthy and capital requirements substantial. Additional event information is available at the B2i Digital event page.
